These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33290543)

  • 1. Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
    Okano S; Homma A; Kiyota N; Tahara M; Hanai N; Asakage T; Matsuura K; Ogawa T; Saito Y; Sano D; Kodaira T; Motegi A; Yasuda K; Takahashi S; Tanaka K; Onoe T; Yokota T; Imamura Y; Ariizumi Y; Akimoto T; Hayashi R
    Jpn J Clin Oncol; 2021 Feb; 51(2):173-179. PubMed ID: 33290543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Any place left for induction chemotherapy for locally advanced head and neck squamous cell carcinoma?
    Burgy M; Leblanc J; Borel C
    Anticancer Drugs; 2018 Apr; 29(4):287-294. PubMed ID: 29420335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
    Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinoma.
    Johnson KCC; Ley J; Oppelt P; Lu J; Gay HA; Daly M; Jackson R; Rich J; Pipkorn P; Paniello RC; Zevallos J; Thorstad W; Adkins DR
    Med Oncol; 2019 Oct; 36(11):93. PubMed ID: 31595355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The application of induction chemotherapy in the treatment of locally advanced head and neck squamous cell carcinoma].
    Zhou L
    Zhonghua Yi Xue Za Zhi; 2024 Jul; 104(26):2373-2377. PubMed ID: 38978359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck.
    Weiss J; Gilbert J; Deal AM; Weissler M; Hilliard C; Chera B; Murphy B; Hackman T; Liao JJ; Grilley Olson J; Hayes DN
    Oral Oncol; 2018 Sep; 84():46-51. PubMed ID: 30115475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction chemotherapy in head and neck cancers: Results and controversies.
    Gau M; Karabajakian A; Reverdy T; Neidhardt EM; Fayette J
    Oral Oncol; 2019 Aug; 95():164-169. PubMed ID: 31345386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options.
    Iocca O; Farcomeni A; Di Rocco A; Di Maio P; Golusinski P; Pardiñas López S; Savo A; Pellini R; Spriano G
    Oral Oncol; 2018 May; 80():40-51. PubMed ID: 29706187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response Rate of Cisplatin Plus Docetaxel as Primary Treatment in Locally Advanced Head and Neck Carcinoma (Squamous Cell Types).
    Nouman M; Haider G; Bukhari N; Yousuf A; Nouman R; Shaikh MR; Hussain S; Pavan B; Rahool R; Memon P; Zahoor S; Mehar K; Sami A
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):825-830. PubMed ID: 32212813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
    Chilimoniuk M; Olszewska E; Maksimowicz T
    Pol Merkur Lekarski; 2010 Dec; 29(174):357-60. PubMed ID: 21298984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy in locally advanced head and neck squamous cell carcinoma.
    Gyawali B; Shimokata T; Honda K; Ando Y
    Cancer Treat Rev; 2016 Mar; 44():10-6. PubMed ID: 26924194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
    Teo M; Karakaya E; Young CA; Dyker KE; Coyle C; Sen M; Prestwich RJ
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):647-53. PubMed ID: 23948462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Intensification and Induction Chemotherapy for High-Risk Locally Advanced Squamous Cell Carcinoma.
    Ghi MG; Paccagnella A
    Curr Treat Options Oncol; 2019 Jan; 20(2):2. PubMed ID: 30635733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there still a role for induction chemotherapy in locally advanced head and neck cancer?
    Mak MP; Glisson BS
    Curr Opin Oncol; 2014 May; 26(3):247-51. PubMed ID: 24651382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
    Sun XS; Tao Y; Le Tourneau C; Pointreau Y; Sire C; Kaminsky MC; Coutte A; Alfonsi M; Boisselier P; Martin L; Miroir J; Ramee JF; Delord JP; Clatot F; Rolland F; Villa J; Magne N; Elicin O; Gherga E; Nguyen F; Lafond C; Bera G; Calugaru V; Geoffrois L; Chauffert B; Zubel A; Zanna C; Brienza S; Crompton P; Rouits E; Gollmer K; Szyldergemajn S; Bourhis J
    Lancet Oncol; 2020 Sep; 21(9):1173-1187. PubMed ID: 32758455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer.
    Spector ME; Rosko AJ; Swiecicki PL; Chad Brenner J; Birkeland AC
    Oral Oncol; 2018 Nov; 86():200-205. PubMed ID: 30409302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.
    Keam B; Lee KW; Lee SH; Kim JS; Kim JH; Wu HG; Eom KY; Kim S; Ahn SH; Chung EJ; Kwon SK; Jeong WJ; Jung YH; Kim JW; Heo DS
    Oncologist; 2019 Jun; 24(6):751-e231. PubMed ID: 30796155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE).
    Terada M; Hara H; Daiko H; Mizusawa J; Kadota T; Hori K; Ogawa H; Ogata T; Sakanaka K; Sakamoto T; Kato K; Kitagawa Y
    Jpn J Clin Oncol; 2019 Dec; 49(11):1055-1060. PubMed ID: 31411696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation.
    Ko EC; Genden EM; Misiukiewicz K; Som PM; Kostakoglu L; Chen CT; Packer S; Kao J
    Oncol Rep; 2012 Feb; 27(2):467-74. PubMed ID: 22020564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700).
    Merlano MC; Denaro N; Vecchio S; Licitra L; Curcio P; Benasso M; Bagicalupo A; Numico G; Russi E; Corvo' R; Bruzzi P;
    Oncology; 2020; 98(11):763-770. PubMed ID: 32629446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.